Disparate patterns of disease time burden in patients with HCC on immunotherapy or tyrosine kinase inhibitors
Background & Aims: While cancer survivorship for hepatocellular carcinoma (HCC) has improved, associated disease time burden in patients taking systemic therapies remains poorly understood. In this study, we used days at home (DAH), a patient-centered metric, to compare the disease time burden b...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-11-01
|
| Serie: | JHEP Reports |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2589555925002605 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|